Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brenipatide vs placebo in uncontrolled moderate-to-severe asthma (China, Phase 2)
CTR20255108Phase 2Active
- Sponsor
- Eli Lilly and Company
- Start
- Mar 2026
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of brenipatide in asthma, sponsored by Eli Lilly and Company. Started Mar 2026; status: active.
02
Drugs
brenipatide
03
Conditions
asthma
Beyond the preview
Go deeper on CTR20255108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20255108.